The Immune System: 2

Overview of the Immune System by Dr. Sidgi Hasson

  • Instructor Information:     * Dr. Sidgi Hasson, Senior Lecturer in Immunology.     * Affiliation: School of Pharmacy and Biomolecular Sciences, LJMU (Liverpool John Moores University).     * Office: James Parsons Building, Room #802.

  • Document Scope: This guide serves as a basic overview of the mechanisms of the immune system (Part 2 of 2).

  • Primary Classification of Innate System Cells:     * Phagocytes.     * Antigen Presenting Cells (APCs).     * Direct Attack Cells.

  • Foundational Concept: Recognition of Self from Non-self.

Fundamental Features of Innate Immune Recognition

  • Recognition Specificity: Innate immunity is characterized by "Limited specificity." It recognizes structures and motifs that characterize microbial pathogens but are absent in mammalian cells.

  • Pathogen-Associated Molecular Patterns (PAMPs): Conserved structures located on or within microbes. Examples include:     * Cell wall peptidoglycans.     * Lipoteichoic acid (LTA).     * Mannans.     * Lipopolysaccharides (LPS).

  • Pattern Recognition Receptors (PRRs): These are receptors of the innate immune system specifically designed to bind PAMPs.

  • Toll-Like Receptors (TLRs) Distribution and Specificity:     * Plasma Membrane Receptors:         * TLR1:TLR2TLR-1:TLR-2 heterodimer: Recognizes bacterial lipopeptides.         * TLR2TLR-2: Recognizes bacterial peptidoglycan.         * TLR4TLR-4: Recognizes Lipopolysaccharides (LPS).         * TLR5TLR-5: Recognizes bacterial flagellin.         * TLR2:TLR6TLR-2:TLR-6 heterodimer: Recognizes bacterial lipopeptides.     * Endosomal Receptors (Intracellular):         * TLR3TLR-3: Recognizes double-stranded RNA (dsRNA).         * TLR7TLR-7: Recognizes single-stranded RNA (ssRNA).         * TLR8TLR-8: Recognizes single-stranded RNA (ssRNA).         * TLR9TLR-9: Recognizes CpG DNA.     * Cytosolic Receptors: Includes RIG1.

Functional Classification and Surface Receptors of Macrophages

  • Macrophage Receptors: Macrophages express multiple receptors to identify bacterial constituents:     * Mannose receptor.     * LPS receptor (CD14CD14).     * TLR4TLR-4.     * Glucan receptor.     * Scavenger receptor.

  • Outcome of Binding:     1. Release of Mediators: Initiates the release of cytokines and small lipid mediators of inflammation.     2. Phagocytosis: Macrophages engulf and digest the bacteria following binding.

Mechanisms of Phagocytosis and Intracellular Killing

  • Phagocytosis by Neutrophils and Macrophages:     * Killing Mechanism: Primarily through activated proteolytic enzymes and oxygen/nitrogen intermediates.     * Respiratory Burst (Oxidative Burst): Mediated by NADPHOxidaseNADPH \, Oxidase. Produces reactive components:         * Hydrogen peroxide (H2O2H_2O_2).         * Superoxide anion (O2O_2^-).         * Nitric oxide (NONO).     * Localization: Killing activity is restricted to phagolysosomes to prevent host tissue damage.

  • Host Protective Enzymes: These enzymes are produced by phagocytes to protect the host cells from the respiratory burst products:     * Catalase: Degrades H2O2H_2O_2.     * Superoxide Dismutase: Converts O2O_2^- into H2O2H_2O_2 and oxygen.

  • The Five Stages of Phagocytosis:     1. Pathogen Recognition: Microbes bind to phagocyte receptors (e.g., Mannose receptor, Mac1integrinMac-1 \, integrin, Scavenger receptor).     2. Attachment and Zipping: The phagocyte membrane zips up and surrounds the microbe.     3. Ingestion: The microbe is internalized into a phagosome.     4. Fusion: The phagosome fuses with a lysosome (containing enzymes) to form a phagolysosome.     5. Phagocyte Activation: Killing of the microbe via intracellular mechanisms.

  • Intracellular Killing Categories:     * Oxygen-Independent: Use of lysosomal enzymes.     * Oxygen-Dependent: Use of the oxidative (respiratory) burst.

Antigen Presenting Cells (APCs)

  • Professional APCs: Dendritic cells, Macrophages (differentiated from monocytes), and B cells.

  • Functional Mechanism:     * Partial digestion of protein antigens into peptides.     * Loading of peptides into Major Histocompatibility Complex (MHC) molecules on the cell surface.     * Presentation of the MHC+peptideMHC + peptide complex to T cells (initiating adaptive immunity).

  • Comparison of Professional APCs:     * Dendritic Cells:         * Antigen Uptake: High (++++++) via macropinocytosis and phagocytosis by tissue-resident cells.         * MHC Expression: Low on tissue-resident cells; High on cells in lymphoid tissues.         * Co-stimulator Delivery: Constitutive by mature, non-phagocytic lymphoid dendritic cells.         * Primary Antigen presented: Viral antigens and allergens.         * Location: Ubiquitous throughout the body.     * Macrophages:         * Antigen Uptake: High (++++++) via phagocytosis.         * MHC Expression: Inducible by bacteria and cytokines.         * Co-stimulator Delivery: Inducible (- to ++++++).         * Primary Antigen presented: Particulate antigens; intracellular and extracellular pathogens.         * Location: Lymphoid tissue, connective tissue, body cavities.     * B Cells:         * Antigen Uptake: High (++++++++) via antigen-specific receptors (immunoglobulin/Ig).         * MHC Expression: Constitutive; increases upon activation.         * Co-stimulator Delivery: Inducible (- to ++++++).         * Primary Antigen presented: Soluble antigens, toxins, viruses.         * Location: Lymphoid tissue, peripheral blood.

Direct Attack Cells and Natural Killer (NK) Cells

  • Cell Lineages:     * Myeloid Origin: Monocytes, Macrophages, Granulocytes (Neutrophils, Eosinophils, Mast cells, Basophils), and Dendritic Cells.     * Lymphoid Origin: Natural Killer (NK) cells and NK/T cells.

  • Cytoplasmic Granules: Direct attack cells contain granules with toxic mediators: histamine, prostaglandins, leukotrienes, tryptase, and eosinophil peroxidase.

  • Natural Killer (NK) Cells:     * Status: Ready to kill; do not require activation.     * Killing Mechanisms (Same as Cytotoxic T-cells):         * Perforin: Inserts pores into the target cell membrane.         * Granzymes: Proteolytic enzymes that enter through perforin pores to induce apoptosis/chromosomal degradation.         * FasL/Fas Interaction: Induces apoptosis in target cells.

  • Regulation of NK Activity:     * Inhibitory Receptors: Bind to standard surface markers (e.g., MHCIMHC-I). If MHCIMHC-I is present, the "kill signal" is suppressed.     * Activating Receptors: Bind to stress-induced glycoproteins on infected or tumor cells. If MHCIMHC-I is absent or low, the activating signal triggers killing.

  • Antibody-Dependent Cellular Cytotoxicity (ADCC):     * The FabFab portion of an antibody binds to epitopes on a foreign cell.     * The NK cell binds to the FcFc portion of that antibody.     * The NK cell releases perforins and granzymes to destroy the cell's cytoskeleton and induce apoptosis.

Lymphocyte Activation, Homing, and Resolution

  • B and T Cell Activation Cycle:     1. Naïve Lymphocyte: Encounters antigen + second signals.     2. Lymphoblast: Conversion to a large lymphocyte cell.     3. Clonal Expansion: Proliferation and differentiation.     4. Effector Cells: B cells become antibody-secreting plasma cells; T cells become cytokine-producing cells or CTLs.     5. Memory Cells: Formation of Memory B and T cells for long-term immunity.     6. Homeostasis: Followed by apoptosis of effector cells once the threat is resolved.

  • Activation and Homing Process:     * Microbes or antigens enter through the epithelium into connective tissue.     * Dendritic cells capture the antigen and transport it via the afferent lymphatic vessel to a regional lymph node.     * Circulating naïve lymphocytes enter the lymph node through arteries.     * Activation and differentiation occur within the lymph node.     * Effector cells and antibodies exit via the efferent lymphatic vessel and enter general circulation to migrate back to the site of infection.     * Memory lymphocytes take up residence in normal tissues for future protection.

Cytokines, Chemokines, and the Inflammatory Response

  • Inflammatory Process:     * Bacteria trigger macrophages to release cytokines and chemokines.     * Vasodilation: Increased vascular permeability leads to redness, heat, and swelling (edema).     * Migration: Inflammatory cells (e.g., neutrophils) migrate into tissue, causing pain through the release of mediators.

  • Specific Cytokines Secreted by Macrophages and Dendritic Cells:     * IL1IL-1: Produced by macrophages/keratinocytes; acts on lymphocytes (enhances response) and the liver (induces acute-phase proteins).     * IL6IL-6: Produced by macrophages/dendritic cells; acts on lymphocytes and the liver (acute-phase protein secretion).     * CXCL8CXCL8 (IL8IL-8): Produced by macrophages/dendritic cells; acts as a chemoattractant for neutrophils.     * IL12IL-12: Produced by macrophages/dendritic cells; acts on naïve T cells to divert immune response to Type 1 proinflammatory secretion.     * TNFαTNF-\alpha: Produced by macrophages/dendritic cells; acts on vascular endothelium to increase fluid loss and cell-adhesion molecules (EE- and PselectinP-selectin).

  • Phagocyte Bactericidal Products:     * Acidification: pH3.54.0pH \approx 3.5 - 4.0 (bacteriostatic/bactericidal).     * Toxic Oxygen: Superoxide (O2O_2^-), H2O2H_2O_2, singlet oxygen (1O21O_2), hydroxyl radical (OHOH^\cdot), hypohalite (OClOCl^-).     * Toxic Nitrogen: Nitric oxide (NONO).     * Antimicrobial Peptides: Defensins and cationic proteins.     * Enzymes: Lysozyme (dissolves Gram-positive walls), Acid hydrolases.     * Competitors: Lactoferrin (binds Fe), Vitamin B12B_{12}-binding protein.

Comparison: Innate vs. Adaptive Immunity

Feature

Innate Immunity

Adaptive Immunity

Recognition

Broad specificity; conserved molecular patterns

Highly specific; specific antigen determinants

Diversity

Limited

Large

Memory

None

Present

Self-Discrimination

Present

Present

Receptor Genes

No rearrangement required

Rearrangement required

Response Time

Rapid (minutes)

Delayed (usually days)

Components

Barriers, Phagocytes, NK cells, Complement

Antibodies, T/B-lymphocytes, APCs

Questions & Discussion

  • The lecture concludes with a placeholder for student questions involving concepts such as B-cells, viruses, and complex immune interactions.

Introduction to Immunology and Immunity

  • Etymology and Definitions     - The word "Immunology" originates from the Latin words Immunitas and Immunes.     - Historical Context in Rome: Initially, these words implied the "Exemption of an Individual from Service or Duty."     - Middle Ages Evolution: The term evolved to mean "Exemption of the Church and its properties and personnel from Civil control."     - Modern Definition of Immunity: The ability of an individual to resist diseases.     - Immunochemistry: Coined by Marcus Annaeus Lucanus, this was the initial term for the study of immune reactions.     - Experimental Discipline: Immunology is defined as an experimental discipline that manipulates the function of the immune system.

  • History of Immunity Research     - Discovery (1882): Élie Metchnikoff initiated immunity research through an experiment using starfish larvae.     - The Experiment: Metchnikoff poured carmine dye on starfish larvae and observed cells that appeared to ingest the dye.     - Findings: Metchnikoff believed he had found the answer to inflammation, suggesting that specialist cells form a protective mechanism against foreign microbes.     - Phagocytosis: This process of ingestion by cells was later termed phagocytosis.

Roles and Functions of the Immune System

  • Primary Roles     - Defense against Microbes: Protecting the body from pathogenic organisms.     - Defense against Tumor Cells: Identifying and killing the growth of tumor cells.     - Homeostasis: The destruction of abnormal or dead cells, such as dead red blood cells (erythrocytes), dead white blood cells (leukocytes), and antigen-antibody complexes.

  • Major Functions of Innate Immunity     - Immediate Response: The initial prevention, control, or elimination of infection until adaptive immune responses are activated.     - Increased Susceptibility: Inhibiting or eliminating any component of innate immunity significantly increases susceptibility to infections, even if the adaptive immune system remains intact.     - Stimulation: The innate system stimulates adaptive immune responses to be optimally effective against different types of microbes (e.g., distinguishing between bacteria and viruses).

Blood Cell Composition and Counts

  • Normal Cell Counts (per mm3mm^3 and percentage of total leukocytes)     - Red Blood Cells (Erythrocytes): 5.0×106cells/mm35.0 \times 10^{6}\,cells/mm^3     - Platelets: 2.5×105cells/mm32.5 \times 10^5\,cells/mm^3     - Leukocytes (Total population distribution):         - Neutrophils: 7.3×103cells/mm37.3 \times 10^3\,cells/mm^3, comprising 5070%50-70\% of leukocytes.         - Lymphocytes: Comprising 2040%20-40\% of leukocytes.         - Monocytes: Comprising 16%1-6\% of leukocytes.         - Eosinophils: Comprising 13%1-3\% of leukocytes.         - Basophils: Comprising <1\% of leukocytes.

Haematopoiesis: The Development of Immune Cells

  • The Process and Lineages     - Pluripotent Hematopoietic Stem Cell: Located in the bone marrow, this is the origin of all blood cells.     - Common Lymphoid Progenitor: Leads to the development of B cells, T cells, and Natural Killer (NK) cells.     - Common Myeloid Progenitor: Leads to the development of granulocyte/macrophage progenitors and megakaryocyte/erythrocyte progenitors.     - Megakaryocyte/Erythrocyte Pathway:         - Megakaryocytes $\rightarrow$ Platelets.         - Erythroblasts $\rightarrow$ Erythrocytes.     - Granulocyte/Macrophage Pathway:         - Neutrophils.         - Eosinophils.         - Basophils.         - Monocytes (precursors of macrophages).         - Unknown precursors lead to mast cells.         - Dendritic cells (can originate from both myeloid and lymphoid precursors).

  • Tissue Maturation and Effector Cells     - B Cells: Mature in the bone marrow and differentiate into plasma cells in the tissues.     - T Cells: Mature in the thymus and become activated T cells in the tissues.     - NK Cells: Differentiate into activated NK cells.     - Monocytes: Circulate in the blood and migrate to tissues to become macrophages.

Innate Immunity Framework

  • Lines of Defense     - Physical and Chemical Innate Defense: Anatomical and physiological barriers.     - Cellular Innate Defense: Specific cell types responding to invasion.

  • A: External Innate Defense (Anatomical Barriers)     - Skin:         - Mechanical: Epithelial cells joined by tight junctions; longitudinal flow of air or fluid.         - Chemical: Fatty acids; antibacterial peptides.         - Microbiological: Normal flora.     - Gut:         - Mechanical: Longitudinal flow of air or fluid.         - Chemical: Low pH; enzymes (pepsin); antibacterial peptides.         - Microbiological: Normal flora.     - Lungs:         - Mechanical: Movement of mucus by cilia.         - Chemical: Antibacterial peptides.     - Eyes/Nose:         - Mechanical: Tears; nasal cilia.         - Chemical: Salivary enzymes; lysozyme.

  • B: Cellular Innate Defense     - Cells of Myeloid Origin:         - Monocytes/Macrophages.         - Dendritic Cells.         - Granulocytes (Neutrophils, Eosinophils, Mast cells, Basophils).     - Cells of Lymphoid Origin:         - Natural Killer (NK) cells.         - NK/T cells.

Characteristics of Innate Immune Cells

  • Monocytes and Macrophages     - Action: Phagocytosis and killing of microorganisms.     - Immune Initiation: Activation of T cells and initiation of the immune response.     - Ontogeny: A monocyte is a young macrophage found in the blood; it migrates to tissues to differentiate.     - Antigen Presentation: Macrophages act as Antigen Presenting Cells (APCs).     - Cytokine Secretion: When exposed to inflammatory stimuli, they secrete cytokines including Tumor Necrosis Factor (TNF), IL-1, IL-6, IL-8, and IL-12.     - Tissue-Specific Macrophages:         - Alveolar Macrophages: Found in the lungs.         - Histiocytes: Found in connective tissue.         - Mesangial Cells: Found in the kidneys.         - Microglial Cells: Found in the central nervous system (e.g., brain).         - Kupffer Cells: Found in the liver.         - Osteoclasts: Found in the bone.

  • Dendritic Cells     - Location: Found mainly in lymphoid tissue.     - Function: Function as the most potent stimulators of T-cell responses (APC function).     - Role: Activation of T cells to initiate adaptive immunity.

  • Mast Cells     - Action: Expulsion of parasites through the release of granules (degranulation).     - Granule Contents: Histamine, leukotrienes, chemokines, and cytokines.     - Clinical Significance: Heavily involved in allergic responses.

  • Neutrophils     - Description: Granulocytes with a multi-lobed (polymorphonuclear) nucleus.     - Granules: Contain compounds such as Defensins, lactoferrin, and MMPs (Matrix Metalloproteinases).     - Function: Professional phagocytes; critical for "clearing" bacterial infections.     - Lifespan: Very short life span, often lasting only a few hours.

  • Eosinophils     - Description: Double-lobed nucleus with orange-stained granules.     - Action: Kills antibody-coated parasites through degranulation.     - Granule Contents: Toxic compounds such as Histamine and peroxide.     - Clinical Significance: Involved in allergic inflammation and fighting parasitic infections.

  • Basophils     - Description: Blue granules containing toxic and inflammatory compounds.     - Granule Contents: Histamine, Heparin, and chemotactic factors.     - Action: Cell-killing cells; mild phagocytic activity.     - Clinical Significance: Important in allergic reactions; sometimes referred to as "blood Mast cells."

  • Natural Killer T (NK-T) Cells     - Characteristics: Share properties of both NK cells and T cells.     - Receptors: Possess αβ\alpha\beta antigen receptors, but these lack the high diversity seen in standard T cells.     - Function: Can both suppress or activate innate and adaptive immune responses.

Adaptive Immunity

  • Cells of the Adaptive Immune System     - Myeloid Origin (Supportive/APC): Monocytes, Dendritic Cells, Macrophages, Granulocytes.     - Lymphoid Origin: NK cells, NK/T cells, T Helper cells, B1 Cells.

  • Lymphoid Organs     - Generative (Primary) Lymphoid Organs: Bone marrow (B cell maturation) and Thymus (T cell maturation).     - Peripheral (Secondary) Lymphoid Organs: Lymph nodes, spleen, mucosal and cutaneous lymphoid tissues.     - Recirculation: Mature lymphocytes recirculate through the blood and lymph between these organs.

  • T Lymphocytes (T Cells)     - T Helper (Th) Cells:         - Markers: Express the T cell receptor (TCR) and CD4 co-receptor.         - Function: Express cytokines to coordinate the entire immune response.         - Subsets: Primarily Th1 and Th2.     - Cytotoxic T Lymphocytes (CTLs):         - Markers: Express the T cell receptor (TCR) and CD8 co-receptor.         - Function: Directly destroy infected cells.

  • B Lymphocytes (B Cells)     - Programming: Each B cell is genetically programmed to produce an antibody of unique specificity.     - Diversity: The human body can theoretically produce 101510^{15} different antibody specificities.     - Receptors: An individual B cell typically has 100,000100,000 identical antibody molecules on its surface acting as B cell receptors.     - Differentiation: Binding of an antigen to the B cell receptor results in differentiation into a plasma cell.

  • B Cell Maturation Stages and Immunoglobulin (Ig) Production     - Stem Cell: No Ig production.     - Pre-B Cell: Produces μ\mu heavy chain (cytoplasmic).     - Immature B Cell: Membrane IgM Expressed.     - Mature B Cell: Membrane IgM and IgD expressed.     - Activated B Cell: Low-rate Ig secretion; undergoes heavy chain isotype switching and affinity maturation.     - Plasma Cell (Antibody-secreting cell): High-rate Ig secretion; reduced levels of membrane Ig.

Core Concepts of Immune Responses

  • Immune Response Defined: This is the collective and coordinated response to a foreign substance within an individual. It is mediated by the specific cells and molecules that constitute the immune system.

  • The Primary Immune Response:     - This response occurs when an antigen comes into contact with the immune system for the first time (1st1^{st} exposure).     - During this phase, the immune system must learn to recognize the specific antigen and determine how to produce antibodies against it.     - The ultimate goal of this phase is the production of memory lymphocytes.

  • The Secondary Immune Response:     - This occurs during the second (2nd2^{nd}), third (3rd3^{rd}), fourth (4th4^{th}), or any subsequent exposure of the individual to the same antigen.     - At this stage, immunological memory has already been established.     - The immune system is capable of initiating antibody production immediately upon re-exposure.

Types of Adaptive Immune Responses

  • Humoral (Antibody-Mediated) Immunity:     - This type of immunity results specifically from the presence and action of antibodies located in the blood and lymph.     - It is mediated by the BB-cell component of the immune response.

  • Cellular (Cell-Mediated) Immunity:     - This type of immunity is mediated by TT cells.     - Key cell types include $T$-helper (THT_H) cells and cytotoxic TT lymphocytes (CTLsCTLs).

  • Developmental Pathways of Immune Cells:     - Activated BB Lymphocytes: These develop into two lineages: antibody-secreting plasma cells and memory BB cells.     - Activated TT Lymphocytes: These develop into memory TT cells, helper TT cells (TH1T_H1, TH2T_H2, or TH17T_H17), and cytotoxic TT cells.

Characteristics of the Primary Antibody Response

  • Initial Exposure: Occurs when an individual is exposed to an antigen for the first time, whether through naturally occurring infection or through a vaccine.

  • Lag Phase (Latent Period):     - There is an initial latent period of several days to weeks before a detectable antibody response is established.     - During this period, no antigen-specific antibody can be detected in the blood.     - The duration of this phase depends on the nature of the antigen, the dose administered, and the route of administration.     - Clinical Correlation: This explains why antibody-based tests, such as those for HIVHIV, are not accurate until several weeks after the initial exposure.

  • Antibody Sequence:     - IgMIgM is the first type of antibody secreted after BB-cell activation during the primary exposure.

  • Phase Kinetics:     - Log Phase: After the lag phase, the antibody titer rises logarithmically to a plateau.     - Affinity: The affinity of antibodies for the antigen's determinants is generally low to moderate.     - Decline Phase: The serum antibody concentration rises to a peak and then declines (decreases quickly), sometimes dropping to very low levels.     - Metabolism: During the decline phase, antibodies are naturally metabolized or cleared from circulation after binding to the antigen. IgMIgM levels tend to decline faster than IgGIgG levels.

Characteristics of the Secondary Antibody Response

  • Trigger: Occurs upon secondary exposure to the same antigen (e.g., re-exposure to a pathogen or receiving a vaccine booster).

  • Heightened Response: BB-cells establish a significantly stronger and faster response.

  • Antibody Class (Isotype) Switching:     - Under the influence of TT-helper cells, the production switches from IgMIgM to other classes, most commonly IgGIgG.     - Other classes produced include IgAIgA (mucosal) or IgEIgE (allergic responses).     - The new class of antibody maintains the same specificity for the original antigen as the initial IgMIgM.

  • Kinetics and Titer:     - Shorter Lag Phase: The latent period is much shorter (14 days1-4\text{ days}) compared to the primary response.     - Higher Titer: Antibody levels rise to much higher levels (1001000100-1000 times more antibodies).     - Duration: The response remains elevated for a significantly longer period.

  • Affinity Maturation: The secondary response produces antibodies with a higher affinity, meaning they bind the antigen more firmly and dissociate less easily.

  • Memory Cells: The secondary response is a direct result of the persistence of antigen-sensitive memory cells from the first response. These cells can persist in the body for years to provide long-term specific immunity.

Comparative Analysis: Primary vs. Secondary Immune Response

Feature

Primary Immune Response

Secondary Immune Response

Trigger

Primary contact with an antigen

Subsequent exposure to the same antigen

Responding Cell

Naïve BB-cell and TT-cell

Memory cells

Lag Phase

Longer (47 days4-7\text{ days}, up to weeks/months)

Shorter (14 days1-4\text{ days}) due to memory cells

Time to Peak Titer

710 days7-10\text{ days}

35 days3-5\text{ days}

Establishment of Immunity

Takes longer to establish

Faster establishment of immunity

Primary Antibody

Mainly IgMIgM; small amounts of IgGIgG

Mainly IgGIgG; sometimes small IgMIgM, IgAIgA, or IgEIgE

Antibody Amount

Usually low; depends on antigen nature

Higher levels (1001000100-1000 times more)

Antibody Decline

Declines rapidly

Remains high for a longer period

Antibody Affinity

Lower affinity

Greater affinity

Primary Location

Mainly lymph nodes and spleen

Bone marrow, then spleen and lymph nodes

Antigen Type

Thymus-dependent and Thymus-independent

Only Thymus-dependent antigens

Mechanism of B-Cell Activation (Dialogue Transcription)

Below is a transcription of the interaction between immune cells during activation as depicted in the lecture materials.

  • B Cell: "An invader… I must inform a TT cell."

  • B Cell to T Cell: "Hey TT cell, look what I found."

  • T Cell: "Hmm.. It looks non-self. Good job, BB."

  • B Cell: "YESSSS.. I knew it!"

  • T Cell: "Here.. CD40LCD40L \u0026 some cytokines."

  • B Cell (Outcome): "I am an activated BB lymphocyte now."